<?xml version="1.0" ?>
<DOC>
   <DOCID>LA102494-0131</DOCID>
   <HEADLINE> ORANGE COUNTY BRIEFLY : CORTEX BEGINS HUMAN TRIALS OF ALZHEIMER ' S DRUG</HEADLINE>
   <TEXT> Cortex Pharmaceuticals Inc. has started human clinical trials with a drug it is developing for treatment of memory_loss resulting from Alzheimer ' s disease . The firm said the study of its Ampakine product is aimed at gaining knowledge of the safety of the compound on humans . The study , being conducted in Berlin , involves 48 people and will last about six weeks . Earlier this year , the company reported that tests of Ampakine on rats showed that animals treated with the drug performed significantly better than untreated animals .</TEXT>
</DOC>
